P SCHOENFELD ASSET MANAGEMENT LP - HUMACYTE INC ownership

HUMACYTE INC's ticker is and the CUSIP is 44486Q111. A total of 13 filers reported holding HUMACYTE INC in Q4 2022. The put-call ratio across all filers is - and the average weighting 0.0%.

Quarter-by-quarter ownership
P SCHOENFELD ASSET MANAGEMENT LP ownership history of HUMACYTE INC
ValueSharesWeighting
Q1 2023$11,493
+52.8%
19,1550.0%0.00%0.0%
Q4 2022$7,520
-65.8%
19,1550.0%0.00%0.0%
Q3 2022$22,000
+29.4%
19,1550.0%0.00%0.0%
Q2 2022$17,000
-54.1%
19,1550.0%0.00%
-50.0%
Q1 2022$37,000
-15.9%
19,1550.0%0.00%0.0%
Q4 2021$44,000
-20.0%
19,1550.0%0.00%
-33.3%
Q3 2021$55,00019,1550.00%
Other shareholders
HUMACYTE INC shareholders Q4 2022
NameSharesValueWeighting ↓
Integrity Capital Management (HK) Ltd 15,830$36,0000.11%
CVI Holdings, LLC 291,832$665,0000.04%
Sio Capital Management, LLC 49,998$114,0000.03%
Exos Asset Management LLC 27,151$62,0000.03%
Ionic Capital Management LLC 100,389$229,0000.03%
Alpine Global Management, LLC 47,500$108,0000.02%
TUDOR INVESTMENT CORP ET AL 236,549$539,0000.01%
LMR Partners LLP 50,000$363,0000.00%
Diameter Capital Partners LP 23,857$54,0000.00%
Virtu Financial LLC 10,314$24,0000.00%
View complete list of HUMACYTE INC shareholders